NNVC plans Phase II trial of NV-387 oral gummies in DR Congo
NNVC says a Phase II clinical trial of NV-387 oral gummies as a treatment for Ebola in DR Congo is set to begin soon.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.